Polyarthrosis: Complications

The following are the most important diseases or complications that may be contributed to by polyarthrosis: Musculoskeletal system and connective tissue (M00-M99). Activated osteoarthritis Movement restriction Joint malpositions Contractures – permanent shortening of the muscles with resulting joint constraint. Symptoms and abnormal clinical and laboratory findings not elsewhere classified (R00-R99). Chronic pain

Polyarthrosis: Cartilage-Protective Agents (Chondroprotectants)

Chondroprotectants inhibit cartilage-degrading substances and thus reduce further loss of protective cartilage. At the same time, they promote the regeneration of cartilage tissue. Furthermore, they are said to have an anti-inflammatory effect. As a result, there is a reduction in pain, swelling and improved joint mobility. The greatest success is achieved by injecting chondroprotectants directly … Polyarthrosis: Cartilage-Protective Agents (Chondroprotectants)

Polyarthrosis: Examination

A comprehensive clinical examination is the basis for selecting further diagnostic steps: General physical examination – including blood pressure, pulse, body weight, height; further: Inspection (viewing). Skin (normal: intact; abrasions/wounds, redness, hematomas (bruises), scars) and mucous membranes. Gait (fluid, limping). Body or joint posture (upright, bent, gentle posture). Malpositions (deformities, contractures, shortenings). Muscle atrophies (side … Polyarthrosis: Examination

Polyarthrosis: Test and Diagnosis

1st order laboratory parameters – obligatory laboratory tests. Small blood count Inflammatory parameters – CRP (C-reactive protein) or ESR (erythrocyte sedimentation rate). Urine status (rapid test for: nitrite, protein, hemoglobin, erythrocytes, leukocytes) incl. sediment, if necessary urine culture (pathogen detection and resistogram, that is, testing of suitable antibiotics for sensitivity / resistance). Renal parameters – … Polyarthrosis: Test and Diagnosis

Polyarthrosis: Drug Therapy

Therapy target The goal of drug therapy for polyarthrosis is to relieve pain and thus improve mobility. Therapy recommendations Depending on the severity of the disease and individual problems, the following medications may be used: Analgesics (painkillers) Non-acid analgesics Nonsteroidal anti-inflammatory drugs (NSAIDs; non steroidal anti- inflammatory drugs, NSAIDs). Selective COX-2 inhibitors (coxibe). Opioid analgesics … Polyarthrosis: Drug Therapy

Polyarthrosis: Diagnostic Tests

Obligatory medical device diagnostics. Radiographs of the affected joints Optional medical device diagnostics – depending on the results of the history, physical examination, laboratory diagnostics and obligatory medical device diagnostics – for differential diagnostic clarification. Computed tomography (CT; sectional imaging procedure (X-ray images from different directions with computer-based evaluation), particularly well suited for the depiction … Polyarthrosis: Diagnostic Tests

Polyarthrosis: Micronutrient Therapy

Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used for supportive therapy: Chondroitin sulfate Glucosamine sulfate The above vital substance recommendations (micronutrients) were created with the help of medical experts. All statements are supported by scientific studies with high levels of evidence. For a therapy recommendation, only clinical studies … Polyarthrosis: Micronutrient Therapy

Polyarthrosis: Surgical Therapy

There are numerous surgical options to alleviate the symptoms and consequences of polyarthrosis and thus significantly improve the quality of life: Joint-preserving surgery Bone stimulating surgeries Joint replacement

Polyarthrosis: Phytotherapeutics

Herbal antirheumatic drugs Herbal preparations can be used for supportive, analgesic (pain-relieving) therapy. Application is mainly: Nettle herb – analgesic and anti-rheumatic effects; dosage: 50-100 g nettle porridge per day. Gamma-linolenic acid (GLA) – e.g. borage oil, evening primrose oil; gamma-linolenic acid is an omega-6 fatty acid that has anti-inflammatory (anti-inflammatory) effects via prostaglandin metabolism; … Polyarthrosis: Phytotherapeutics

Polyarthrosis: Prevention

To prevent polyarthrosis, attention must be paid to reducing individual risk factors. Behavioral risk factors Pleasure food consumption Tobacco (smoking) – nicotine abuse promotes loss of articular cartilage in the knee joint (gonarthrosis) Physical activity Underloading of the cartilage: Lack of physical activity – since cartilage gets its micronutrients from the synovial fluid, it relies … Polyarthrosis: Prevention

Polyarthritis: Analgesics-Anti-Inflammatories

Therapeutic target Relief of symptoms Therapy recommendations For non-active polyarthrosis: analgesic/pain reliever paracetamol (best tolerated). In activated polyarthrosis (abraded cartilage or bone material inflamed): non-steroidal anti-inflammatory drugs (NSAIDs), e.g. diclofenac [no long-term therapy!]Note: No diclofenac in cardiovascular risk! Affected are patients with heart failure (cardiac insufficiency) of NYHA classes II to IV, coronary artery disease … Polyarthritis: Analgesics-Anti-Inflammatories